Human Vaccines Administered Orally Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Vaccines Administered Orally
1.2 Key Market Segments
1.2.1 Human Vaccines Administered Orally Segment by Type
1.2.2 Human Vaccines Administered Orally Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Vaccines Administered Orally Market Overview
2.1 Global Market Overview
2.1.1 Global Human Vaccines Administered Orally Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Vaccines Administered Orally Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Vaccines Administered Orally Market Competitive Landscape
3.1 Global Human Vaccines Administered Orally Sales by Manufacturers (2019-2024)
3.2 Global Human Vaccines Administered Orally Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Vaccines Administered Orally Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Vaccines Administered Orally Sales Sites, Area Served, Product Type
3.6 Human Vaccines Administered Orally Market Competitive Situation and Trends
3.6.1 Human Vaccines Administered Orally Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Vaccines Administered Orally Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Vaccines Administered Orally Industry Chain Analysis
4.1 Human Vaccines Administered Orally Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Vaccines Administered Orally Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Vaccines Administered Orally Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Vaccines Administered Orally Sales Market Share by Type (2019-2024)
6.3 Global Human Vaccines Administered Orally Market Size Market Share by Type (2019-2024)
6.4 Global Human Vaccines Administered Orally Price by Type (2019-2024)
7 Human Vaccines Administered Orally Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Vaccines Administered Orally Market Sales by Application (2019-2024)
7.3 Global Human Vaccines Administered Orally Market Size (M USD) by Application (2019-2024)
7.4 Global Human Vaccines Administered Orally Sales Growth Rate by Application (2019-2024)
8 Human Vaccines Administered Orally Market Segmentation by Region
8.1 Global Human Vaccines Administered Orally Sales by Region
8.1.1 Global Human Vaccines Administered Orally Sales by Region
8.1.2 Global Human Vaccines Administered Orally Sales Market Share by Region
8.2 North America
8.2.1 North America Human Vaccines Administered Orally Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Vaccines Administered Orally Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Vaccines Administered Orally Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Vaccines Administered Orally Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Vaccines Administered Orally Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Human Vaccines Administered Orally Basic Information
9.1.2 Merck Human Vaccines Administered Orally Product Overview
9.1.3 Merck Human Vaccines Administered Orally Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Human Vaccines Administered Orally SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Human Vaccines Administered Orally Basic Information
9.2.2 GSK Human Vaccines Administered Orally Product Overview
9.2.3 GSK Human Vaccines Administered Orally Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Human Vaccines Administered Orally SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Human Vaccines Administered Orally Basic Information
9.3.2 Sanofi Human Vaccines Administered Orally Product Overview
9.3.3 Sanofi Human Vaccines Administered Orally Product Market Performance
9.3.4 Sanofi Human Vaccines Administered Orally SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Human Vaccines Administered Orally Basic Information
9.4.2 Lanzhou Institute Human Vaccines Administered Orally Product Overview
9.4.3 Lanzhou Institute Human Vaccines Administered Orally Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Human Vaccines Administered Orally Basic Information
9.5.2 Serum Institute Human Vaccines Administered Orally Product Overview
9.5.3 Serum Institute Human Vaccines Administered Orally Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Human Vaccines Administered Orally Basic Information
9.6.2 Valneva Human Vaccines Administered Orally Product Overview
9.6.3 Valneva Human Vaccines Administered Orally Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Human Vaccines Administered Orally Basic Information
9.7.2 Shanghai United Cell Human Vaccines Administered Orally Product Overview
9.7.3 Shanghai United Cell Human Vaccines Administered Orally Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Human Vaccines Administered Orally Basic Information
9.8.2 Bibcol Human Vaccines Administered Orally Product Overview
9.8.3 Bibcol Human Vaccines Administered Orally Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Human Vaccines Administered Orally Basic Information
9.9.2 PaxVax Human Vaccines Administered Orally Product Overview
9.9.3 PaxVax Human Vaccines Administered Orally Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Human Vaccines Administered Orally Basic Information
9.10.2 Vabiotech Human Vaccines Administered Orally Product Overview
9.10.3 Vabiotech Human Vaccines Administered Orally Product Market Performance
9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Human Vaccines Administered Orally Basic Information
9.11.2 Tiantan Biological Human Vaccines Administered Orally Product Overview
9.11.3 Tiantan Biological Human Vaccines Administered Orally Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Human Vaccines Administered Orally Basic Information
9.12.2 EuBiologics Human Vaccines Administered Orally Product Overview
9.12.3 EuBiologics Human Vaccines Administered Orally Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Human Vaccines Administered Orally Basic Information
9.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Product Overview
9.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Product Market Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Human Vaccines Administered Orally Basic Information
9.14.2 Bio-Med Human Vaccines Administered Orally Product Overview
9.14.3 Bio-Med Human Vaccines Administered Orally Product Market Performance
9.14.4 Bio-Med Business Overview
9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
10 Human Vaccines Administered Orally Market Forecast by Region
10.1 Global Human Vaccines Administered Orally Market Size Forecast
10.2 Global Human Vaccines Administered Orally Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Vaccines Administered Orally Market Size Forecast by Country
10.2.3 Asia Pacific Human Vaccines Administered Orally Market Size Forecast by Region
10.2.4 South America Human Vaccines Administered Orally Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Vaccines Administered Orally by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Vaccines Administered Orally Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Vaccines Administered Orally by Type (2025-2030)
11.1.2 Global Human Vaccines Administered Orally Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Vaccines Administered Orally by Type (2025-2030)
11.2 Global Human Vaccines Administered Orally Market Forecast by Application (2025-2030)
11.2.1 Global Human Vaccines Administered Orally Sales (Kilotons) Forecast by Application
11.2.2 Global Human Vaccines Administered Orally Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Vaccines Administered Orally Market Size Comparison by Region (M USD)
Table 5. Global Human Vaccines Administered Orally Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Vaccines Administered Orally Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Vaccines Administered Orally Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Vaccines Administered Orally Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccines Administered Orally as of 2022)
Table 10. Global Market Human Vaccines Administered Orally Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Vaccines Administered Orally Sales Sites and Area Served
Table 12. Manufacturers Human Vaccines Administered Orally Product Type
Table 13. Global Human Vaccines Administered Orally Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Vaccines Administered Orally
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Vaccines Administered Orally Market Challenges
Table 22. Global Human Vaccines Administered Orally Sales by Type (Kilotons)
Table 23. Global Human Vaccines Administered Orally Market Size by Type (M USD)
Table 24. Global Human Vaccines Administered Orally Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Table 26. Global Human Vaccines Administered Orally Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Vaccines Administered Orally Market Size Share by Type (2019-2024)
Table 28. Global Human Vaccines Administered Orally Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Vaccines Administered Orally Sales (Kilotons) by Application
Table 30. Global Human Vaccines Administered Orally Market Size by Application
Table 31. Global Human Vaccines Administered Orally Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Table 33. Global Human Vaccines Administered Orally Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Vaccines Administered Orally Market Share by Application (2019-2024)
Table 35. Global Human Vaccines Administered Orally Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Vaccines Administered Orally Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Table 38. North America Human Vaccines Administered Orally Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Vaccines Administered Orally Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Vaccines Administered Orally Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Vaccines Administered Orally Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Vaccines Administered Orally Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Human Vaccines Administered Orally Basic Information
Table 44. Merck Human Vaccines Administered Orally Product Overview
Table 45. Merck Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Human Vaccines Administered Orally SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Human Vaccines Administered Orally Basic Information
Table 50. GSK Human Vaccines Administered Orally Product Overview
Table 51. GSK Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Human Vaccines Administered Orally SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Human Vaccines Administered Orally Basic Information
Table 56. Sanofi Human Vaccines Administered Orally Product Overview
Table 57. Sanofi Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Human Vaccines Administered Orally SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute Human Vaccines Administered Orally Basic Information
Table 62. Lanzhou Institute Human Vaccines Administered Orally Product Overview
Table 63. Lanzhou Institute Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute Business Overview
Table 65. Lanzhou Institute Recent Developments
Table 66. Serum Institute Human Vaccines Administered Orally Basic Information
Table 67. Serum Institute Human Vaccines Administered Orally Product Overview
Table 68. Serum Institute Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute Business Overview
Table 70. Serum Institute Recent Developments
Table 71. Valneva Human Vaccines Administered Orally Basic Information
Table 72. Valneva Human Vaccines Administered Orally Product Overview
Table 73. Valneva Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Valneva Business Overview
Table 75. Valneva Recent Developments
Table 76. Shanghai United Cell Human Vaccines Administered Orally Basic Information
Table 77. Shanghai United Cell Human Vaccines Administered Orally Product Overview
Table 78. Shanghai United Cell Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai United Cell Business Overview
Table 80. Shanghai United Cell Recent Developments
Table 81. Bibcol Human Vaccines Administered Orally Basic Information
Table 82. Bibcol Human Vaccines Administered Orally Product Overview
Table 83. Bibcol Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bibcol Business Overview
Table 85. Bibcol Recent Developments
Table 86. PaxVax Human Vaccines Administered Orally Basic Information
Table 87. PaxVax Human Vaccines Administered Orally Product Overview
Table 88. PaxVax Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. PaxVax Business Overview
Table 90. PaxVax Recent Developments
Table 91. Vabiotech Human Vaccines Administered Orally Basic Information
Table 92. Vabiotech Human Vaccines Administered Orally Product Overview
Table 93. Vabiotech Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vabiotech Business Overview
Table 95. Vabiotech Recent Developments
Table 96. Tiantan Biological Human Vaccines Administered Orally Basic Information
Table 97. Tiantan Biological Human Vaccines Administered Orally Product Overview
Table 98. Tiantan Biological Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Tiantan Biological Business Overview
Table 100. Tiantan Biological Recent Developments
Table 101. EuBiologics Human Vaccines Administered Orally Basic Information
Table 102. EuBiologics Human Vaccines Administered Orally Product Overview
Table 103. EuBiologics Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. EuBiologics Business Overview
Table 105. EuBiologics Recent Developments
Table 106. Panacea Biotec Ltd Human Vaccines Administered Orally Basic Information
Table 107. Panacea Biotec Ltd Human Vaccines Administered Orally Product Overview
Table 108. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Panacea Biotec Ltd Business Overview
Table 110. Panacea Biotec Ltd Recent Developments
Table 111. Bio-Med Human Vaccines Administered Orally Basic Information
Table 112. Bio-Med Human Vaccines Administered Orally Product Overview
Table 113. Bio-Med Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Bio-Med Business Overview
Table 115. Bio-Med Recent Developments
Table 116. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Basic Information
Table 117. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Overview
Table 118. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Halfkin Bio-Pharmaceuticals Business Overview
Table 120. Halfkin Bio-Pharmaceuticals Recent Developments
Table 121. Global Human Vaccines Administered Orally Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Human Vaccines Administered Orally Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Human Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Human Vaccines Administered Orally Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Human Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Human Vaccines Administered Orally Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Human Vaccines Administered Orally Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Human Vaccines Administered Orally Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Human Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Human Vaccines Administered Orally Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Human Vaccines Administered Orally Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Human Vaccines Administered Orally Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Human Vaccines Administered Orally Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Human Vaccines Administered Orally Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Human Vaccines Administered Orally Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Human Vaccines Administered Orally Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Human Vaccines Administered Orally Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Human Vaccines Administered Orally
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Vaccines Administered Orally Market Size (M USD), 2019-2030
Figure 5. Global Human Vaccines Administered Orally Market Size (M USD) (2019-2030)
Figure 6. Global Human Vaccines Administered Orally Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Vaccines Administered Orally Market Size by Country (M USD)
Figure 11. Human Vaccines Administered Orally Sales Share by Manufacturers in 2023
Figure 12. Global Human Vaccines Administered Orally Revenue Share by Manufacturers in 2023
Figure 13. Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Vaccines Administered Orally Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Vaccines Administered Orally Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Vaccines Administered Orally Market Share by Type
Figure 18. Sales Market Share of Human Vaccines Administered Orally by Type (2019-2024)
Figure 19. Sales Market Share of Human Vaccines Administered Orally by Type in 2023
Figure 20. Market Size Share of Human Vaccines Administered Orally by Type (2019-2024)
Figure 21. Market Size Market Share of Human Vaccines Administered Orally by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Vaccines Administered Orally Market Share by Application
Figure 24. Global Human Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 25. Global Human Vaccines Administered Orally Sales Market Share by Application in 2023
Figure 26. Global Human Vaccines Administered Orally Market Share by Application (2019-2024)
Figure 27. Global Human Vaccines Administered Orally Market Share by Application in 2023
Figure 28. Global Human Vaccines Administered Orally Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Figure 30. North America Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 32. U.S. Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Vaccines Administered Orally Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Vaccines Administered Orally Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 37. Germany Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Vaccines Administered Orally Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Vaccines Administered Orally Sales Market Share by Region in 2023
Figure 44. China Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Vaccines Administered Orally Sales and Growth Rate (Kilotons)
Figure 50. South America Human Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 51. Brazil Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Vaccines Administered Orally Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Vaccines Administered Orally Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Vaccines Administered Orally Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Vaccines Administered Orally Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Vaccines Administered Orally Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Vaccines Administered Orally Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Vaccines Administered Orally Sales Forecast by Application (2025-2030)
Figure 66. Global Human Vaccines Administered Orally Market Share Forecast by Application (2025-2030)
Industry Market Size
